Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Catalent Inc. (CTLT)

78.01   -1.14 (-1.44%) 07-10 16:00
Open: 78.76 Pre. Close: 79.15
High: 78.985 Low: 77.25
Volume: 1,494,973 Market Cap: 12,779M
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics and Specialty Drug Delivery segment engages in the drug substance development and manufacturing; drug product clinical and commercial manufacturing; and integrated clinical and commercial supply solutions for protein and gene therapy biologics and specialty small molecules through injection, inhalation, and ophthalmic routes.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 79.053 - 79.453 79.453 - 79.709
Low: 76.294 - 76.826 76.826 - 77.165
Close: 77.236 - 78.04 78.04 - 78.554

Technical analysis

as of: 2020-07-10 4:26:41 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 92.54     One year: 108.09
Support: Support1: 72.27    Support2: 67.97
Resistance: Resistance1: 79.23    Resistance2: 92.54
Pivot: 73.54
Moving Average: MA(5): 76.13     MA(20): 72.83
MA(100): 62.78     MA(250): 57.37
MACD: MACD(12,26): 1.22     Signal(9): 0.60
Stochastic oscillator: %K(14,3): 95.21     %D(3): 93.63
RSI: RSI(14): 63.64
52-week: High: 80.52  Low: 31.04  Change(%): 44.5
Average Vol(K): 3-Month: 155955  10-Days: 124138

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CTLT has closed below upper band by 3.2%. Bollinger Bands are 27.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 10 Jul 2020
Why Do Investors Care About Catalent, Inc. (CTLT) - The News Heater

Fri, 10 Jul 2020
Catalent: A New Buy in Vaccine Development -

Thu, 09 Jul 2020
Is Catalent's (NYSE:CTLT) Share Price Gain Of 155% Well Earned? - Yahoo Finance

Tue, 07 Jul 2020
How Much Are Catalent, Inc. (NYSE:CTLT) Insiders Spending On Buying Shares? - Simply Wall St

Tue, 07 Jul 2020
Catalent, Inc. (CTLT) Bears Seem To Be Pulling The Price Back - Invest Million

Wed, 01 Jul 2020
Scott Gunther Sells 2,824 Shares of Catalent Inc (NYSE:CTLT) Stock - MarketBeat

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug ManufacturersSpecialty & Generic
Shares Out. (M) 164
Shares Float (M) 154
% Held by Insiders 0.67
% Held by Institutions 99.09
Shares Short (K) 3,000
Shares Short P. Month (K) 2,710

Stock Financials

EPS 0.690
EPS Est This Year 1.630
EPS Est Next Year 1.820
Book Value (p.s.) 14.130
Profit Margin 4.79
Operating Margin 12.72
Return on Assets (ttm) 4.0
Return on Equity (ttm) 6.2
Qtrly Rev. Growth 23.2
Gross Profit (p.s.) 4.915
Sales Per Share 17.520
EBITDA (p.s.) 3.707
Qtrly Earnings Growth -34.10
Operating Cash Flow (M) 356
Levered Free Cash Flow (M) 9

Stock Valuations

PE Ratio 113.04
PEG Ratio
Price to Book value 5.52
Price to Sales 4.45
Price to Cash Flow 35.94

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.